==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 26
IDThPPIDNamePeptide SequenceLengthFunctional ClassificationDiseaseBrandCompanyPhysical AppearanceRoute of AdministartionCategoryTarget
1005Th1002CetuximabHeavy chain:QVQLKQSG Full view243IIIcCancerErbituxImClone Systems IncSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulatesIntravenous infusionAntineoplastic Agents Epidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
1074Th1013Epoetin alfaAPPRLICDSRVLERYLLEAK Full view166IbHematologicalEpogenAmgen Inc.Sterile, colorless liquidSubcutaneous InjectionAnti-anemic Agents, Hematinics Erythropoietin receptor
1078Th1013Epoetin alfaAPPRLICDSRVLERYLLEAK Full view166IbHematologicalProcritOrtho BiotechSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solutionIntravenous(IV) or Subcutaneous (SC) administration.Anti-anemic Agents, Hematinics Erythropoietin receptor
1194Th1025Intravenous ImmunoglobulinIGG1:PSALTQPPSASGSLG Full view250IaImmunologicalFlebogammaInstituto Grifols SASterile, clear or slightly opalescent and colorless to pale yellow, liquidIntravenous infusionImmunosuppressive Agents, Immunologic factors, Anti-infective agents High affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
1341Th1049Interferon beta-1aMSYNLLGFLQRSSNFQCQKL Full view166IbCancer/Infectious/ImmunologicalAvonexBiogen IncLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.Intramuscular InjectionImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1379Th1058Interferon alfacon-1CDLPQTHSLGSRRTLMLLAQ Full view165IbImmunological/InfectiousINFERGENKadmon Pharmaceuticals, LLC.Sterile, clear, colorless, preservative-free liquidSubcutaneous InjectionAntiviral Agents and Immunosuppressive Agents Interferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
1389Th1062RituximabHeavy Chain: QVQLQQP Full view664IIaCancer/ImmunologicalRituxanBiogen Idec Inc., and Genentech USA, IncSterile, clear, colorless, preservative-free liquid concentrate Intravenous administrationAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents B-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
1465Th1089PalivizumabVH region: QVTLRESG< Full view120IIIaInfectiousSynagisMedImmuneSterile, preservative-free liquid solutionIntramuscular injectionAntiviral Agents N.A.
1474Th1094PanitumumabN.A. Full view0IIaCancerVectibixAmgen IncSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulatesN.A.N.A. Epidermal growth factor receptor
1550Th1119TocilizumabN.A. Full view0IIaImmunologicalACTEMRAGenentechSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5Intravenous infusion, Subcutaneous injectionN.A. Interleukin-6 receptor subunit alpha
1560Th1121Pertuzumablight chain DIQMTQSP Full view664IIIcCancerPerjetaGenentechSterile, clear to slightly opalescent, colorless to pale brown liquidIntravenous infusionMonoclonal antibodies Receptor tyrosine-protein kinase erbB-2
1624Th1137TeduglutideHGDGSFSDEMNTILDNLAAR Full view33IaMalabsorption disorderGattexNPS Pharmaceuticals, IncClear, colorless to light-straw–colored liquid.Subcutaneous injectionN.A. Glucagon-like peptide 2 receptor
1627Th1138RaxibacumabN.A. Full view0IIaImmunological/InfectiousRAXIBACUMABGSKSterile, liquid formulation in single-dose vialsN.A.Anti-Infective Agents and Monoclonal antibodies Protective antigen
1636Th1142ObinutuzumabN.A. Full view0IIbCancerGazyvaGenentechSterile, clear, colorless to slightly brown, preservative free liquid concentrateIntravenous infusionAntineoplastic Agents B-lymphocyte antigen CD20
1768Th1186Human rabies virus immune globulinNA Full view0IIIaInfectious DiseaseHyperab Rabies Immune Globulin HumanCutter Med & Biol, Division Of Miles Canada Ltd.LiquidIntramuscularNA NA
1770Th1186Human rabies virus immune globulinNA Full view0IIIaInfectious DiseaseImogam Rabies Inj 150unit/mlPasteur mÉrieux Serums Et Vaccins, s.a.Clear, pale yellow to light brown liquidIntramuscularNA NA
1772Th1187Human Rho(D) immune globulinNA Full view0IIIbImmunological DisordersHyp Rho D Inj 16.5%Cutter Med & Biol, Division Of Miles Canada Ltd.liquidIntramuscularNA NA
1779Th1187Human Rho(D) immune globulinNA Full view0IIIbImmunological DisordersWinrho Sdf (liquid Formulation)Aptevo Biotherapeutics LlcliquidIntramuscular; IntravenousNA NA
1793Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersGamastanCutter Med & Biol, Division Of Miles Canada Ltd.liquidIntramuscularImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1795Th1190Immune Globulin HumanIGG1: PSALTQPPSASGSL Full view1338IIIbImmunological DisordersHyqviaBaxalta Us Inc.LiquidIntravenous infusionImmunologic Factors; Immunosuppressive Agents; Anti-Infective Agents High affinity immunoglobulin gamma Fc receptor I; High affinity immunoglobulin gamma Fc receptor IB; Low affinity immunoglobulin gamma Fc region receptor II-a; Low affinity immunoglobulin gamma Fc region receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II-c; Low affinity immunoglobulin gamma Fc region receptor III-A; Low affinity immunoglobulin gamma Fc region receptor III-B; Complement C3; Complement C4-A; Complement C4-B; Complement C5.
1813Th1204OfatumumabOfatumumab Heavy Cha Full view483IIIcCancerArzerraGlaxo Smith Kline LlcLiquidIntravenousAntineoplastic and Immunomodulating Agents
1814Th1205ObiltoxaximabNA Full view0IIIaInfectious DiseaseAnthimElusys Therapeutics, Inc.LiquidIntravenous infusionNA NA
1815Th1206NivolumabHeavy Chain Sequence Full view710IIIcCancerOpdivoE.R. Squibb & Sons, L.L.C.LiquidIntravenousAntineoplastic and Immunomodulating Agents Programmed cell death protein 1
1826Th1216Anthrax immune globulin humanNA Full view0IIaImmunological DisordersANTHRASILCangene CorporationLiquidIntravenousPlasma derivative Protective antigen
1831Th1221C1 Esterase Inhibitor (Recombinant) NA Full view0IIaCardiac DisordersRuconestTjoapack Netherlands BvPowder and liquid for solutionIntravenousBlood and Blood Forming Organs Complement C1r subcomponent, Complement C1s subcomponent, Plasma kallikrein, Coagulation factor XII, Prothrombin, Coagulation factor XI, Tissue-type plasminogen activator
1850Th1237Somatropin recombinantFPTIPLSRLFDNAMLRAHRL Full view191IbHormonal DisordersNutropinAQGenentech Inc.Sterile liquidSubcutaneousHormones, Hormone Substitutes, and Hormone Antagonists Growth hormone receptor, Prolactin receptor